These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 4670729)

  • 1. The influence of some drugs on platelet aggregation and adhesion.
    Bielawiec M; Perzanowski A; Myśliwiec M
    Acta Univ Carol Med Monogr; 1972; 53():211-4. PubMed ID: 4670729
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative effects of platelet adhesiveness by phenformin combined with ethylestrenol or stanozolol.
    Chakrabarti R
    Acta Univ Carol Med Monogr; 1972; 53():261-2. PubMed ID: 4670736
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of phenformin and stanozol administration on lipid metabolism in patients with occlusive vascular diseases].
    Perzanowski A; Bielawiec M; Myśliwiec M
    Pol Tyg Lek; 1972 Jan; 27(5):174-6. PubMed ID: 5010762
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of phenformin plus stanozolol on fibrinolysis, platelet adhesiveness and blood lipids in patients with recurrent venous thrombosis.
    Bielawiec M; Myśliwiec M; Perzanowski A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1974; 101(3):483-8. PubMed ID: 4139068
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical investigations on long-term activation of fibrinolysis by anabolic steroids.
    Bielawiec M; Bodzenta A; Lukjan H; Kiersnowska-Rogowska B; Kłoczko J; Myśliwiec M; Dabrowski S; Tymiński W; Czestochowska E
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(1-2):223-9. PubMed ID: 2427405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hemokinetic and metabolic action of 7-2-(3-pyridyl-methylamino)-ethyl-theophylline nicotinate as a basis of medical treatment of chronic obliterating peripheral arteriopathy].
    Cascio F
    Minerva Cardioangiol; 1973 Nov; 21(11):715-31. PubMed ID: 4776567
    [No Abstract]   [Full Text] [Related]  

  • 7. The behaviour of the platelet-leukocyte aggregation in thrombotic conditions.
    Bielawiec M; Kiersnowska-Rogowska B; Myśliwiec M; Perzanowski A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1975; 102(2):220-9. PubMed ID: 50987
    [No Abstract]   [Full Text] [Related]  

  • 8. [The vasoactivogram in the treatment of peripheral arteriopathies].
    Romeo S; Spinella G; Sciacchitanto D
    Angiologia; 1975; 27(1):7-25. PubMed ID: 1111377
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of surheme on improved blood flow in limbs].
    Wesolowski J; Hubl S; Godziemba-Maliszewska E
    Wiad Lek; 1972 Jul; 25(14):1297-300. PubMed ID: 5054661
    [No Abstract]   [Full Text] [Related]  

  • 10. The role of phenformin and ethyloestrenol or stanozolol in the treatment of decreased fibrinolytic states. (Cutaneous vasculitis, Raynaud's disease, Behcet's syndrome, recurrent deep vein thrombosis and post myocardial infarction).
    Menon IS
    Acta Univ Carol Med Monogr; 1972; 52():19-23. PubMed ID: 4669824
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects on platelet stickiness and fibrinolysis of phenformin combined with ethyloestrenol or stanozolol.
    Chakrabarti R; Fearnley GR; Evans JF
    Lancet; 1970 Mar; 1(7647):591-3. PubMed ID: 4190544
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of Sadamin on some blood clotting parameters and fibrinolysis in patients with obliterative arteriosclerosis of lower limb arteries].
    Kiersnowska B; Bielawiec M; Lukjan H; Korfel B; Rogowski F; Dowzyk W
    Pol Tyg Lek; 1973 Mar; 28(11):400-3. PubMed ID: 4694796
    [No Abstract]   [Full Text] [Related]  

  • 13. [Use of a new sympatholytic drug in therapy of chronic peripheral obliterating artery diseases].
    Vittori C; Taborelli G; Taborelli R
    Minerva Cardioangiol; 1965 Sep; 13(9):585-91. PubMed ID: 5851172
    [No Abstract]   [Full Text] [Related]  

  • 14. [Contribution to the study of internal temperatures in subjects with arterial diseases with obliterating evolution. I. Effects of sodium nicotinate, theophylline-ethylenediamine and theophylline nicotinate].
    Blasi A; Licciardello M
    Boll Soc Ital Cardiol; 1966; 11(4):1111-5. PubMed ID: 5992024
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clearing and anti-platelet-aggregation effects of a heparinoid of natural origin].
    Marini U; Bastoni F; Gibelli A
    Clin Ter; 1974 Oct; 71(1):13-31. PubMed ID: 4138995
    [No Abstract]   [Full Text] [Related]  

  • 16. [Experiences with the treatment of peripheral vascular diseases with Xavin].
    Brücknerová O
    Vnitr Lek; 1973 Apr; 19(4):379-86. PubMed ID: 4699159
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical considerations and functional data on the use of the association of kallikrein and meso-inositol hexanicotinate in the therapy of obliterating arteriopathy].
    Blasi A; Licciardello M
    Clin Ter; 1966 Jul; 38(2):121-58. PubMed ID: 5990194
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of arteriopathies of limbs by xanthinol nicotinate].
    Elbaz C
    Phlebologie; 1969; 22(1):105-11. PubMed ID: 5775643
    [No Abstract]   [Full Text] [Related]  

  • 19. [Peripheral arterial disease--in the field of internal medicine].
    Seki K
    Nihon Rinsho; 1970 Mar; 28 Suppl():854-5. PubMed ID: 5430911
    [No Abstract]   [Full Text] [Related]  

  • 20. [The use of intrathecal phenol solutions in vascular diseases of the lower exremities].
    Papo I; Visca A
    Minerva Cardioangiol; 1967 Feb; 15(2):169-71. PubMed ID: 5632412
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.